We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Gilead Acquires Nimbus Therapeutics’

News   Apr 05, 2016

 
Gilead Acquires Nimbus Therapeutics’
 
 
Advertisement
 

RELATED ARTICLES

Molecular Switch Turns on Brown Fat Energy Burn

News

An international research team have discovered how to activate brown fat in humans, which may lead to new treatments for type 2 diabetes and obesity.

READ MORE

Discovering the Strategies Tumor Cells Use To Evade Immune Attack

News

A new study has uncovered the strategies tumor cells use to evade immune system attack. The method developed for this work contributes to a better understanding of the "arms race" between immune defense and disease.

READ MORE

Existing Alcoholism Drug Potentially Effective Against COVID-19

News

Chemists have used molecular modeling to identify two existing drugs that could be used to fight SARS-CoV-2. These are disulfiram, which is used to treat alcoholism, and neratinib, an experimental drug being used to treat breast cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE